Drugs / Trimipramine

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) SURMONTIL — 1979-06-12 fda.gov ↗

Trials 3

1978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT07263438 Nov 2025 → Mar 2028 expected glioblastoma Centre Hospitalier Universitaire Vaudois Recruiting No outcome recorded
Phase 31 trial
Phase 3 NCT02374567 Jan 2015 → Jun 2017 anxiety disorder, dementia, depressive disorder, schizophrenia +1 Hannover Medical School Terminated No outcome recorded
Phase 41 trial
Phase 4 NCT02237937 Sep 2011 → Dec 2014 major depressive disorder HolsboerMaschmeyer NeuroChemie GmbH Unknown No outcome recorded

Evidence & citations 17 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Trimipramine ClinicalTrials.gov intervention name — accepted as the source's own label NCT07263438 ↗
2

NCT02374567 ↗

NCT02237937 ↗

Known as 7162 RP ChEMBL registry synonym — accepted as the source's own label CHEMBL644 ↗
Known as IL 6001 ChEMBL registry synonym — accepted as the source's own label CHEMBL644 ↗
Known as NSC-758386 ChEMBL registry synonym — accepted as the source's own label CHEMBL644 ↗
Known as Stangyl ChEMBL registry synonym — accepted as the source's own label CHEMBL644 ↗
Known as Surmontil ChEMBL registry synonym — accepted as the source's own label CHEMBL644 ↗
Known as Trimeproprimine ChEMBL registry synonym — accepted as the source's own label CHEMBL644 ↗
Known as Trimipramina ChEMBL registry synonym — accepted as the source's own label CHEMBL644 ↗
Known as TRIMIPRAMINE MALEATE ChEMBL registry synonym — accepted as the source's own label CHEMBL644 ↗
Action Inhibit “Serotonin 2c (5-HT2c) receptor antagonist” CHEMBL644 ↗
4

“Serotonin 2a (5-HT2a) receptor antagonist” CHEMBL644 ↗

“Norepinephrine transporter inhibitor” CHEMBL644 ↗

“Histamine H1 receptor antagonist” CHEMBL644 ↗

“Dopamine D2 receptor antagonist” CHEMBL644 ↗

Modality Small molecule — CHEMBL644 ↗
Route Oral “daily oral intake” NCT07263438 ↗
Target DRD2 “Dopamine D2 receptor antagonist” CHEMBL644 ↗
Target HRH1 “Histamine H1 receptor antagonist” CHEMBL644 ↗
Target HTR2A “Serotonin 2a (5-HT2a) receptor antagonist” CHEMBL644 ↗
Target HTR2C “Serotonin 2c (5-HT2c) receptor antagonist” CHEMBL644 ↗
Target SLC6A2 “Norepinephrine transporter inhibitor” CHEMBL644 ↗